WebJun 15, 2024 · Adapun dosis obatnya menyesuaikan dengan sediaan obat, kegunaan, dan usia pasiennya. Berikut adalah dosis obat cytarabine berdasarkan laman MIMS.com. 1. Meningitis leukemia. Dosis awal untuk … WebJ W Yates, H J Wallace Jr, R R Ellison, J F Holland. PMID: 4586956 No abstract available. Publication types Clinical Trial MeSH terms Adolescent Adult Aged Clinical Trials as Topic ... Cytarabine / therapeutic use*
CLOFARABINE - Welcome to RobHolland.com
WebAug 1, 2024 · Cytarabine Injection, an antineoplastic agent, is a sterile preserved solution for intravenous or subcutaneous administration, and is available in a 500 mg (20 mg per mL) multi-dose vial. Each mL contains … WebK R Rai, J F Holland, O J Glidewell, V Weinberg, K Brunner, J P Obrecht, H D Preisler, I W Nawabi, D Prager, R W Carey, M R Cooper, F Haurani, J L Hutchison, R T Silver, G … high street marshfield wi
Cytarabine - Wikipedia
WebK R Rai, J F Holland, O J Glidewell, V Weinberg, K Brunner, J P Obrecht, H D Preisler, I W Nawabi, D Prager, R W Carey, M R Cooper, F Haurani, J L Hutchison, R T Silver, G Falkson, P Wiernik, H C Hoagland, C D Bloomfield, G W James, A Gottlieb, S V Ramanan, J Blom, N I Nissen, A Bank, R R Ellison, F Kung, P Henry, O R McIntyre, S K Kaan CYTARABINE (sye-tare'a-been) ARA-C, Cytosar-U, Cytosine Arabinoside, DepoCyt, Tarabine Classifications:antineoplastic; antimetabolite, purine antagonist; immunosuppressant Prototype: 6-mercaptopurine Pregnancy Category: D Availability 10 mg/mL liposomal, 20 mg/mL, 100 mg, 500 mg, 1g, 2 g injection … See more Pyrimidine analog with cell phase specificity affecting rapidly dividing cells in S phase (DNA synthesis). In certain conditions prevents development of cell from G1to S phase. Interferes with DNA and RNA synthesis. See more To induce and maintain remission in acute myelocytic leukemia, acute lymphocytic leukemia, and meningeal leukemia and for treatment of lymphomas. Used in combination with other antineoplastics in established … See more Antineoplastic agent which has strong myelosuppressant activity. Immunosuppressant properties are exhibited by obliterated cell-mediated immune responses, such as delayed hypersensitivity skin … See more History of drug-induced myelosuppression; immunization procedures; pregnancy (category D) particularly during first trimester, lactation. … See more WebNov 19, 2010 · In these studies, cytarabine was given as an infusion at a dose of 50mg/m 2 /d over 12 hours on days 1–5, and at a dose of 2g/m 2 /d over 3 hours on days 2–5 with etoposide at 200mg/m 2 /d on days 2–5. Both responders and non-responders were eligible to proceed to autologous stem cell transplant ... how many days till june 14 2022